Aiste Monika Jakstaite

Cardiologist with clinical and research interest in advanced heart failure | Hannover Medical School

[EuroIntervention @EuroInterventio]

In symptomatic moderate AS, the stress aortic valve index (SAVI) identifies a high-risk subgroup not captured by conventional metrics and independently predicts the need for valve intervention (HR 5.7).

https://t.co/90M4bBCnBJ

@RobEerdekens @RikAdrMD @drnvanmieghem
@AshkanEftekhar1

#AorticStenosis #Cardiology #StructuralHeart

[Tobias Koenig @TKoenigMD]

TAVI-Update 2025 in Hannover! Das #TAVI-Team der #MHH lädt ein zu "TAVI im Gespräch" am 01.10.2025 in der #GastFreundSchafft Hannover mit @JBauersachsMD, @BSchmack_MD, @PfefferMD, @DBerlinerMD, @SiewekeJT und Christian Frerker

[Aiste Monika Jakstaite @Jakstaite_A]

Cardiac Arrest in Apparently Healthy, Young Adults https://t.co/1QVXlCfBNI

[BiykemBozkurt @BiykemB]

Sacubitril/Valsartan in patients with HF & deterioration in eGFR to <30 with therapy. Continuation of ARNi was associated with persistent clinical benefit and no incremental risk. @JACCJournals #JACCHF https://t.co/m5BvBm0B4m

[JACC Journals @JACCJournals]

Diagnosis of #HFpEF in pts w/ #AFib: HFA-PEFF and H2FPEF scores demonstrated moderate accuracy. (HFA-PEFF AUC 0.633, H2FPEF AUC 0.707). These data suggest invasive hemodynamic diagnosis of HFpEF is the gold standard in this cohort https://t.co/1pyaf38gCu #JACCHF

[Henrike Hillmann @HenrikeHillmann]

Nicht verpassen - @YoungDgk #interaktiv - Spotlight Interventionelle Kardiologie 12.-13.09.24:
💡1ste Schritte im HK
💡Nachtdienste meistern
💡optimales Zeitmanagement
💡 EKG
u.v.m.!
💥Highlight: Hands on Simulatortraining!
Anmeldungen freigeschaltet: https://t.co/rrOOLSB4j1

[European Society of Cardiology @escardio]

Aficamten for the treatment of symptomatic obstructive hypertrophic #cardiomyopathy - SEQUOIA-HCM study.

#HeartFailure2024 #HFA_ESC

[Emanuele Monda @MondaEmanuele]

Our Paper Just Published on @JACCJournals

Prevalence of Pathogenic Variants
in Cardiomyopathy-Associated Genes in Acute Myocarditis

https://t.co/ml50qjoepd

@ath_bakalakos @glimongelli @dougcannie

[Jeroen Dauw @JeroenDauw]

Natriuresis-guided decongestion improves diuretic response. Results of our #ENACTHF study were published today in @CircHF

A thread 🧵 below

https://t.co/ytmU30Aw6m

#cardiotwitter #heartfailure #HFA_ESC #MedTwitter

@wilfriedmullens

[Anju Bhardwaj MD FACC @docbhardwaj]

🔥🔥🔥Value of Invasive Hemodynamics assessment in #LVAD patients: State of Art Review in @JACCJournals #JACCHF by team @FilioBillia

🏷️ ⬆️ burden of HRAEs with #LVAD
🏷️ IHA allow speed optimization & symptom evaluation with tailored Mx
🏷️Echo doesn’t reflect unloading

[Julia Seller @JuliaSellerm]

The best of heart failure in 2023 ➡️ 10 key points you can't miss!

#heartfailure #CardioTwitter https://t.co/t1WPZljA2r

[Steven Hsu @stevenhsu_md]

We are excited to share our work on #RV function in #LVAD patients. Using RV P-V loops, we find occult RV contractile dysfunction in LVAD patients (vs controls), which correlates to the loss of septal contractility from LV unloading.

https://t.co/4mOQxfxp5p

[Aiste Monika Jakstaite @Jakstaite_A]

Grateful for the chance to present our findings on long-term outcomes post LVAD explant at #EUMS2023 ➡️ strategies to promote myocardial recovery have to be actively employed‼️@JBauersachsMD @ruhparwar @JanSchmitto @BSchmack_MD @StavrosDrakos @MHH_life @YoungDgk @DGK_org

[Matt DiMeglio DO, MBA @Matt_DiMeglio]

How do you relate the parameters and hemodynamics of continuous-flow left ventricular assist devices (LVAD)?

Here's a🧵 that seeks to answer this question for trainees on their CHF rotation

Special thanks to @AHajduczok and @gregorytgibson for their help with this topic

[European Society of Cardiology @escardio]

#Afib ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical therapy in patients with end-stage #HeartFailure

#ESCCongress CASTLE-HTx trial - Catheter ablation versus medical therapy to treat atrial fibrillation in end-stage heart failure.

[Andrew J Sauer MD @AndrewJSauer]

🔥 BREAKING 🔥

@MkosiborodMD from @MidAmericaHeart

❇️STEP-HFpEF, semaglutide
Obesity-phenotype HFpEF

🔆 Dual primary endpt. achieved

1. 🔼 health status (KCCQ)
2. 🔽 weight
3. 🚶 🔼 walk distance
4. Reduced NTproBNP

The beginning of a new era of therapies for this phenotype

[Peter Lüdike @luedike]

🔥Happy to see our DEST HF study finally published ▶️Diastolic Exercise Stress Testing in Heart Failure with Preserved Ejection Fraction in @ESC_Journals @escardio @DGK_org @YoungDgk @YoungDZHK @BDI_eV @HFA_President @HeartFailureFrm @BSHeartFailure
https://t.co/I9NOSgTn4f

[Henry Han @HanCardiomd]

#MRA initiation during admission is associated with improved outcomes irrespective of EF in patients with acute #HeartFailure

In-hospital MRA therapy linked to ⬇️ risk of mortality, CV death, HF🏥 or renal failure - all independent of LVEF

https://t.co/TI1U0lmzfx

#EJHF @ESC_Journals @MarcoMetra @EJHFEiC @HFA_President

[European Society of Cardiology Journals @ESC_Journals]

The big squeeze: balancing the hemodynamics of cardiac tamponade and superior vena cava syndrome. https://t.co/efbgp2fAOi

#EHJCaseReports @KardiologieHH @aayshacader @ANazmiCalik @TJ_Yeo @Phiso_de @EHJCREiC @FarhanaAra